fda import alert semaglutide tirzepatide green list Creates to Block Certain Ingredients Used for Compounding GLP-1s FDA sends warning letter after

If you are considering switching from semaglutide to tirzepatide , that is a fundamentally different transition since you are changing medications entirely, not just pharmacies

This can help individuals eat less and lose weight

Track Progress: Monitor changes beyond the scale using a combination of body measurements, photos, and strength improvements

GLP-1 receptor agonists such as semaglutide (marketed under brand names Ozempic, Wegovy, and Rybelsus) and the dual GIP/GLP-1 agonist tirzepatide (marketed under brand names Mounjaro and Zepbound) are FDA-approved prescription medications for specific uses in type 2 diabetes management and, in some cases, chronic weight management

This is great news for those looking to shed some pounds, as it suggests that the medication can lead to significant and sustained weight loss